期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (1)
The study aimed to examine the impact of a community-based health education intervention on the awareness and attitude of influenza and Streptococcus ......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (1)
Genetic optimization of Nucleic Acid immunogens is important for potentially improving their immune potency. A COVID-19 DNA vaccine is in phase III cl......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (1)
Purpose To highlight the scientific progress in immunotherapy of urological cancer by identifying and analyzing the 100 top-cited (T100) articles from......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (5)
Mumps cases were reported frequently when a routine dose measles-mumps-rubella(MMR) achieved high coverage in Quzhou. The supplementary immunization a......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (7)
In China, progress to include the RV vaccine in the national immunization program (NIP) is slow. The only two vaccines, the Lanzhou lamb rotavirus vac......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (5)
Plain Language Summary What is the context? There are currently no accessible data on the efficacy and safety of inactivated COVID-19 vaccinations in ......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (1)
Previous studies have shown that seasonal influenza strikes annually causing millions to fall sick and several hundred thousand to die globally. Hence......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (1)
In recent years, the Global Polio Eradication Initiative has gradually implemented a global shift in polio immunization programs. Few studies cover po......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (5)
COVID-19 vaccine booster shots are necessary to provide durable immunity and stronger protection against the emerging SARS-CoV-2 variants. As a major ......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (5)
Getting vaccinated against SARS-CoV-2 lowers the risk of severe infections. In Hong Kong, two vaccine types are offered: CoronaVac by Sinovac Biotech ......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (5)
This study aimed to understand the willingness of and affecting factors of non-national immunization program (non-NIP) vaccines among children's paren......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (7)
The increased dose of hepatitis B vaccine has been adopted for newborns since 2013 in Fujian, China. However, little is known about the impact of this......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (5)
Invasive meningococcal disease (IMD) caused by Neisseria meningitidis (Nm) continues to be a global public health concern. Understanding the prevalenc......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (7)
Emergency vaccination (EV) is used as effective postexposure prophylaxis (PEP) to control varicella outbreaks within 3-5 days. However, the advantages......
期刊： HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022; 18 (1)
Purpose This population-based cross-sectional study was conducted to explore whether parents are willing to pay to vaccinate their children against CO......
